Stock TBET TIBET PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Tibet Pharmaceuticals, Inc.

Equities

TBET

VGG886151023

Market Closed - OTC Markets
Other stock markets
 17:06:07 13/05/2024 BST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Tibet Pharmaceuticals, Inc. -.--% -.--%
2017 Tibet Pharmaceuticals, Inc. announced a financing transaction CI
2013 Hong Yu, Chairman and Chief Executive Officer of TBET, cancelled the acquisition of the remaining 77.9% stake in Tibet Pharmaceuticals, Inc.. CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hong Yu, Chairman and Chief Executive Officer of TBET, cancelled the acquisition of the remaining 77.9% stake in Tibet Pharmaceuticals, Inc..
CI
Hong Yu, Chairman and Chief Executive Officer of TBET, signed a non-binding proposal letter to acquire the remaining 77.9% stake in Tibet Pharmaceuticals, Inc. for $34.7 million.
CI
Tibet Pharmaceuticals, Inc. Signs Letter of Intent to Cooperate with Anhui Taihe Pharmaceutical Group Co., Ltd
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBET Stock
  4. News Tibet Pharmaceuticals, Inc.
  5. Highlights